Description: This article explores telemedicine's impact on the health care system, health care costs, and actuarial pricing.

Description: The coming wave of biosimilars could dramatically affect prescription drug costs and benefit strategies over the next several years. The launch of many Humira biosimilars in 2023 is the Big Event that will largely determine the impact of the biosimilar wave. Payers have many decisions to make about coverage and formulary tiers. What factors will drive payer decision-making?

Description: This session discussion is about a review of experience under PPOs, measuring the success of PPOs, PPOs affect on employer health care expenditures, employee utilization of PPOs, the future of PPOs. From Record of the Society of Actuaries Vol. 11, No. 4A.

Description: This is an article about the rising costs of health care and what it means for student health care plans. Health Section News, Issue 46

Description: Discover the key components of value-based care (VBC) contracts and their impact on provider credibility. Learn about benchmarks, measurement period results, and the unique challenges providers face in managing insurance risk. Gain insights into reducing costs and aligning financial incentives in the US healthcare market.

Description: Panelists at this session of the SOA 1998 Maui II Spring Meeting offer several approaches to creative provider reimbursement where a single capitation and fee schedule was not the best solution.

Description: Discusses what the prevalent form of health-care financing will be in the future: Health Maintenance Organizations [HMOs], Preferred Provider Organizations [PPOs], Managed Care fee-for-service insurance contracts [Managed Care], and Triple-Option products. From the 1987 Record of Society of Actuaries, Vol. 13, No. 1.

Description: Joe Wurzburger, Staff Fellow at the SOA, shares his views and insights about the health care industry in general and the Health Section's role in particular.

Description: This research material provides an evaluation and synthesis of the methodologies and data samples used on characterizing health care fraud

Description: This panel discussion session focuses on national health insurance in Great Britain and Canada. Discussion items include plan features and costs, impact on providers from health care provided outside the national plan, inclusion of private health insurance and prepayment systems. Vol. 5 No. 4